Pliant Therapeutics to Assemble Expert Panel to Review BEACON-IPF Trial Data; Shares Jump
In This Article:
Pliant Therapeutics' (PLRX) shares rose by than 32% in recent Thursday trading after the company sai
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.